Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science.
She leads the research for the Drug Science Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis. Dr Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.
She holds Honorary Fellowships at both Imperial College London and King’s College London and is scientific advisor to the Primary Care Cannabis Network.
On the London 2026 programme
- Day 1 · Main Stage · 12:00 pmEvidence First: Designing Public Policy Through Data and Trials